Cargando…

Immune Cells, Superheroes or Villains?: Targeting the Bad Guys to Treat Myxomatous Mitral Valve Disease

[Figure: see text]

Detalles Bibliográficos
Autor principal:	Lincoln, Joy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research - Preclinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849463/ https://www.ncbi.nlm.nih.gov/pubmed/36687275 http://dx.doi.org/10.1016/j.jacbts.2022.06.020

Ejemplares similares

Myxomatous degeneration of the mitral valve
por: Neto, Felippe Lazar, et al.
Publicado: (2018)

Therapeutic CCR2 Blockade Prevents Inflammation and Alleviates Myxomatous Valve Disease in Marfan Syndrome
por: Xu, Na, et al.
Publicado: (2022)

Plasmatic Dimethylarginines in Dogs With Myxomatous Mitral Valve Disease
por: Valente, Carlotta, et al.
Publicado: (2021)

Intestinal Complication With Myxomatous Mitral Valve Diseases in Chihuahuas
por: Araki, R., et al.
Publicado: (2021)

Myxomatous Mitral Valve with Prolapse and Flail Scallop
por: Fan, Jerry, et al.
Publicado: (2016)

Myxomatous Mitral Valve Disease with Mitral Valve Prolapse and Mitral Annular Disjunction: Clinical and Functional Significance of the Coincidence
por: Wunderlich, Nina C., et al.
Publicado: (2021)

Safety of Dietary Guanidinoacetic Acid: A Villain of a Good Guy?
por: Ostojic, Sergej M.
Publicado: (2021)

Bacterial Bad Guys
por: Weinhold, B
Publicado: (2003)

Serum Concentrations of Leptin and Adiponectin in Dogs with Myxomatous Mitral Valve Disease
por: Kim, H.‐S., et al.
Publicado: (2016)

Review of Diagnostic and Therapeutic Approach to Canine Myxomatous Mitral Valve Disease
por: Menciotti, Giulio, et al.
Publicado: (2017)

Assessment of heart rate turbulence in dogs with myxomatous mitral valve disease
por: dos Santos, Julio P., et al.
Publicado: (2021)

Pro-Inflammatory and Immunological Profile of Dogs with Myxomatous Mitral Valve Disease
por: Piantedosi, Diego, et al.
Publicado: (2022)

Telotristat ethyl reverses myxomatous changes in mice mitral valves
por: Wang, Xinmei, et al.
Publicado: (2022)

Evaluation of progression of chronic kidney disease in dogs with myxomatous mitral valve disease
por: Yun, Hyejin, et al.
Publicado: (2023)

Hemodynamic Effects of Protamine Infusion in Dogs with Myxomatous Mitral Valve Disease Undergoing Mitral Valvuloplasty
por: Yoshida, Tomohiko, et al.
Publicado: (2022)

The Mitral INsufficiency Echocardiographic score: A severity classification of myxomatous mitral valve disease in dogs
por: Vezzosi, Tommaso, et al.
Publicado: (2021)

Are anti-HIV IgAs good guys or bad guys?
por: Zhou, Mingkui, et al.
Publicado: (2014)

Distinct Mitral Valve Proteomic Profiles in Rheumatic Heart Disease and Myxomatous Degeneration
por: Martins, Carlo de Oliveira, et al.
Publicado: (2014)

Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease
por: Li, Qinghong, et al.
Publicado: (2015)

Prevalence and Prognostic Importance of Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease
por: Borgarelli, M., et al.
Publicado: (2015)

Predictive model for the detection of pulmonary hypertension in dogs with myxomatous mitral valve disease
por: MIKAWA, Shoma, et al.
Publicado: (2014)

Reliability of symmetric dimethylarginine in dogs with myxomatous mitral valve disease as kidney biomarker
por: Savarese, Alice, et al.
Publicado: (2018)

Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs
por: Nakamura, K., et al.
Publicado: (2017)

ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs
por: Keene, Bruce W., et al.
Publicado: (2019)

Prevalence and risk factors for atrial fibrillation in dogs with myxomatous mitral valve disease
por: Guglielmini, Carlo, et al.
Publicado: (2020)

Radiographic quantification of left atrial size in dogs with myxomatous mitral valve disease
por: Lam, Christopher, et al.
Publicado: (2021)

Serum Proteomic Profiles Reflect the Stages of Myxomatous Mitral Valve Disease in Dogs
por: Rešetar Maslov, Dina, et al.
Publicado: (2023)

Pharmacokinetics of pimobendan after oral administration to dogs with myxomatous mitral valve disease
por: McManamey, Anna K., et al.
Publicado: (2023)

Mitral annular disjunction in myxomatous mitral valve disease: a relevant abnormality recognizable by transthoracic echocardiography
por: Carmo, Pedro, et al.
Publicado: (2010)

Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity
por: Valente, Carlotta, et al.
Publicado: (2020)

Serotonin Concentrations in Platelets, Plasma, Mitral Valve Leaflet, and Left Ventricular Myocardial Tissue in Dogs with Myxomatous Mitral Valve Disease
por: Cremer, S.E., et al.
Publicado: (2014)

Echocardiographic Estimates of Right Ventricular Systolic Function in Dogs with Myxomatous Mitral Valve Disease
por: Chapel, E.H., et al.
Publicado: (2017)

Comparative Transcriptomic Profiling and Gene Expression for Myxomatous Mitral Valve Disease in the Dog and Human
por: Markby, Greg R., et al.
Publicado: (2017)

A Genomic Study of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels
por: Bionda, Arianna, et al.
Publicado: (2020)

The chromogranin A-derived peptides catestatin and vasostatin in dogs with myxomatous mitral valve disease
por: Höglund, Katja, et al.
Publicado: (2020)

Echocardiographic predictors of first onset of atrial fibrillation in dogs with myxomatous mitral valve disease
por: Baron Toaldo, Marco, et al.
Publicado: (2020)

Comparative transcriptomic profiling of myxomatous mitral valve disease in the cavalier King Charles spaniel
por: Markby, G. R., et al.
Publicado: (2020)

Effect of pimobendan on left atrial function in dogs with preclinical myxomatous mitral valve disease
por: Sarcinella, Fabio, et al.
Publicado: (2019)

Peripheral blood lymphocyte subtypes in dogs with different stages of myxomatous mitral valve disease
por: Druzhaeva, Natalia, et al.
Publicado: (2021)

Echocardiographic estimation of left ventricular‐arterial coupling in dogs with myxomatous mitral valve disease
por: Osuga, Tatsuyuki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tsjem1vv6ppo17r7g33265vgue